Please provide your email address to receive an email when new articles are posted on . Primary care providers frequently order prostate cancer screenings for older patients, even when they provide ...

Prostate cancer is the second-leading cause of cancer death in men with more than 34,000 deaths in the U.S. each year, according to the American Cancer Society. But guidelines for prostate cancer ...

Prostate cancer is the second-leading cause of cancer death in men with more than 34,000 deaths in the U.S. each year, according to the American Cancer Society. But guidelines for prostate cancer ...

A prospective observational study linked circulating tumor DNA fraction and copy-number burden with progression and survival ...

Prostate cancer is a common cancer in men that, once it progresses to the later stages, has serious morbidity and mortality consequences as well as burdensome financial issues for patients, the ...

A molecular feature in prostate cancer, called endogenous retroviral (ERV) RNA, has been found to have prognostic value and also distinguish differences between men of African and European or Middle ...

Table 2. Examples of Disproven Regimens in Phase III Trials Although these agents with demonstrated efficacy have been valuable to date, there is little question that current therapies have ...

A single-patient report from China shows that PSMA and FDG PET scans, stable blood markers and biopsy each told different ...

image: Chris Gillette, Ph.D., associate professor of PA Studies for Wake Forest University School of Medicine, collaborates with colleagues view more WINSTON-SALEM, N.C. – Jan. 4, 2023 – Prostate ...